Sensei Biotherapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€0.00 - Gross profit
€0.00 - SG&A expenses
€10.55M - R&D expenses
€13.25M - EBITDA
-€23.26M - D&A
€571.21K - EBIT
-€24.62M - Interest expenses
€30.15K - EBT
-€23.11M - Tax expenses
€0.00 - Net income
-€23.11M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€513.48K - Changes in working capital
€89.60K - Operating cash flow
-€20.91M - Capex
€13.78K - Other investing cash flow
€215.39K - Net investing cash flow
€22.15M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€502.28K - Other financing cash flow
-€169.73K - Net financing cash flow
-€672.01K - Foreign exchange effects
€0.00 - Net change in cash
€573.79K - Cash at end of period
€10.82M - Free cash flow
-€20.89M
Balance sheet
- Cash and cash equivalents
€10.82M - Cash and short-term investments
€24.66M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€813.30K - Total current assets
€25.48M - Property, plant & equipment
€1.88M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€20.68K - Total non-current assets
€1.90M - Total assets
€27.38M - Accounts payable
€302.40K - Short-term debt
€1.69M - Other current liabilities
€1.34M - Total current liabilities
€3.34M - Long-term debt
€1.03M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€513.48K - Total liabilities
€3.85M - Common stock
€0.00 - Retained earnings
-€235.94M - Other equity
-€9.48K - Total equity
€23.53M - Total liabilities and shareholders' equity
€27.38M
Company information
- Market capitalization
€12.71M - Employees
14 - Enterprise Value
€1.57M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-98.2% Much better than peer group: -408.1% - ROA
-
-84.4% Better than peer group: -99.7% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-164.5% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.65M